A simple solid-phase immunoassay for quantification of vesicular stomatitis virus (VSV) is described. Infected cultures are lysed with deoxycholate. Samples of the lysates are transferred to PVC immunoassay plates and the amount of virus protein adsorbed to the plates is then quantified by sequential incubation with antiserum against VSV proteins and 125I-labeUed Protein A. The decrease of VSV protein in interferon (IFN)-treated cultures is correlated with inhibition of formation of infectious virions; its quantification therefore allows accurate measurement of the antiviral effect. The applicability of the immunoassay for measuring the virus yield is not restricted to cells exhibiting a virus cytopathic effect. Moreover, since the decrease of virus protein is obtained at IFN concentrations lower than those that reduce cell killing by the virus, the assay provides a more sensitive measure for the IFN effect than that obtained by 'cytopathic effect inhibition' assays. While the nature of the virus function that IFN suppresses is very different for differing types of viruses, the cause for that suppression is, for many viruses, the same. It is a reflection of the fact that those virus proteins which carry out the functions are synthesized at reduced rates in the IFN-treated cells (Sonnabend & Friedman, 1973) . A more direct and general approach for quantification of the antiviral effect should, therefore, consist of determining the level of virus proteins in the ceils rather than measuring activities which they display.
INTRODUCTION
A variety of different techniques have been suggested for quantification of the antiviral effect of interferon (IFN) (for reviews, see Finter, 1973; Stewart, 1979) , mostly based on measuring various activities of the virus as an alternative to the tedious quantification of the viruses by plaque assay. Thus, a reduction in haemagglutinin activity, a decrease in reverse transcriptase activity [for measuring the effect of IFNs in cells infected with retroviruses (Aboud et aL, 1976) ], decrease of virus RNA synthesis [in ceils infected with various RNA viruses (Alien & Givon, 1970) ] and a decrease of cell killing in cultures infected with cytopathic viruses have all been used.
While the nature of the virus function that IFN suppresses is very different for differing types of viruses, the cause for that suppression is, for many viruses, the same. It is a reflection of the fact that those virus proteins which carry out the functions are synthesized at reduced rates in the IFN-treated cells (Sonnabend & Friedman, 1973) . A more direct and general approach for quantification of the antiviral effect should, therefore, consist of determining the level of virus proteins in the ceils rather than measuring activities which they display.
In this study we describe a simple, solid-phase immunoassay for the proteins of vesicular stomatitis virus (VSV) and show that it can be applied for quantifying the effect of IFN on this virus. Comparison of this assay with a cytopathic effect assay showed that direct quantification of the decrease in viral protein is preferable to the secondary method of measuring viral cytopathy. Several applications of the immunoassay for the study of IFN have already been described elsewhere (Schattner et al., 1982a, b; Weissenbach et al., 1980; Wallach, 1982 Wallach, , 1983 Wallach et al., 1982) .
METHODS

Cells.
The human cell lines used in this study were: HU (obtained through Dr I. Vlodavsky, The Hadassah University Hospital, Jerusalem), CCL-6 (obtained from the American Type Culture Collection) and HeLa (obtained from Flow Laboratories). FS 11 is a strain of human foreskin fibroblasts, established in our laboratory.
0022-1317/83/0000-5628 $02.00© 1983 SGM In addition, we have used monkey BSC-I fibroblasts, bovine MDBK cells, baby hamster kidney (BHK) cells and mousc L-929 cells. All cclls wcre grown in Dulbecco's modified Eagle's medium in the presence of I0 ~ foetal calf serum (FCS).
VSV and antiserum against its proteins. VSV of the Indiana serotype was re-cloned several times in BSC-1 ceils and used at a low passage number. Virions, produced either in BSC-1 cells or in a spinner culture of BHK cells, were purified on a sucrose gradient and on a tartrate-glycerol gradient, as previously described . Rabbits were injected intramuscularly with 0-5 mg of purified virions emulsified in complete Freund's adjuvant and 5 months later with a further 2 mg injected by the same route, as well as 0.5 mg of u.v.-irradiated virions supplied intravenously. A month later, the animals were again injected intramuscularly with 0-5 mg of purified virions which had been lysed in 0.5 ~ Nonidet P40 (NP40), fixed in 3 ~ formaldehyde and, after extensive dialysis, mixed with complete Freund's adjuvant. The rabbits were bled a week later. The titre of antibodies in the sera was found to be saturating in the solid-phase immunoassay at a dilution of up to 1:200.
Immunoassay of virus proteins and quantification of the IFN effect
Treatment with IFN. Cells were seeded in microwells at concentrations of 2.5 x l0 s cells in 18 mm microwells or 3.5 x 104 cells in 9 mm microwells. A few hours later, serial dilutions of the solutions to be tested and IFN samples of known concentrations were applied to the cells_ Infection by the virus. Twelve to twenty-four h after application of IFN, growth medium was removed from the cells and the virus was applied in growth medium containing 2~ FCS, at a multiplicity of 10 p.f.u./cell (50 gl/ microwell). Several cell samples were incubated without virus and others with virus but without pretreatment by IFN. Two h after application of the virus, the virus-containing growth medium in the microwells was replaced by a fresh medium containing 10~ FCS (100 gl/microwell) and the cells were incubated for a further 10 to 20 h. The infected cultures were kept frozen before further processing for the assay of the virus proteins. Optimal duration of incubation with the virus could be estimated by observing the development of virus cytopathic effect.
Transfer of the VSVproteins. The virus protein was first solubilized by adding to the culture medium an equal volume of a solution of 0.5 ~ sodium deoxycholate in 0.1 N-sodium carbonate buffer, pH 9-6. Lysis of the cells by the detergent could be hastened by incubation at 37 °C for about 20 min. Fifty gl aliquots of the solubilized protein were then transferred to V-shaped microwells in PVC radioimmunoassay plates (Dynatech 1-220-25) using a 'Titertek' multichannel pipette.
Immunoradiometric assay. The PVC plate was incubated for 2 h in a humidified chamber at 37 °C. Nonadsorbed protein was rinsed off with a solution of 0.05 ~ Tween-20 in phosphate-buffered saline (Tween-PBS). Anti-VSV antiserum, diluted in Tween-PBS, was then applied in a volume of 20 ktl to each well and the plate was incubated again for 2 h at 37 °C. After rewashing with Tween-PBS, the plate was incubated for 1 h at 37 °C with ~2SI-labelled Protein A (20 gl, 5 x 106 ct/min per ml of 1 ~ bovine serum albumin in PBS). The plate was then washed with Tween-PBS and the amount of label adsorbed to each well was determined in a y-counter. Control values (usually less than 5~) were subtracted. Initially, we purified the antibodies by adsorption and elution from immobilized protein of VSV (Weissenbach et al., 1980) . We later omitted this purification step since we found the control values (bound radioactivity in the absence of VSV protein) to be equally low with the whole serum.
Definition of the unit ofantiviral activity. We refer here to a l unit of IFN as that amount which, when present in 1 ml, gives a 50~ reduction in virus yield. The concentrations of IFN necessary to cause a reduction in virus yield are shown in this study to be significantly lower than those causing reduction of virus cytopathic effect. Since the latter parameter is widely used to quantify IFN, concentrations referred to as 1 U/ml in this study might be lower than in many others. Indeed, we found that the currently available international standards for both IFN-ct (NIH G-023-901-527) and IFN-fl (NIH G-023-902-527) cause a 50~ reduction in VSV protein binding at concentrations lower than those defined by their producers as 1 U/ml (at 0-43 U/ml IFN-ct on MDBK cells and at 0.24 U/ml IFN-fl on human foreskin fibroblasts).
Quantification ofcytopathic effect by neutral red uptake. The assay was performed as described by Finter (1969) . Materials. IFN-fl was induced by poly(rI), poly(rC) in FS11 cells and partially purified on a DEAE-Sephadex column. IFN-ct was induced in Namalwa lymphoblastoid cells by Sendal virus and partially purified by adsorption to immobilized anti-interferon antibody. Protein A was purchased from Pharmacia and iodinated with Bolton Hunter reagent (Amersham International) as specified by the manufacturers, or obtained in the labelled form either from Amersham International or from New England Nuclear. Tween-20 was obtained from Sigma.
RESULTS
Development of the immunoassay
As a first step in establishing an immunoassay for VSV protein, we determined optimal conditions for the binding of virus protein to solid-phase immunoassay plates. Low binding of virus protein to PVC plates observed after incubation with cell growth medium which contained virus could be significantly enhanced by adding detergents to the virus suspensions (Fig. 1 a) . Comparison of several detergents suggested a correlation between an increase in binding to the PVC and the effectiveness of the detergent in dissociating the proteins of VSV. Thus, deoxycholate which causes release of both of the G and M proteins of VSV and a disruption of the viral nucleocapsid (Cartwright et al., 1970a, b) was significantly more effective than NP40, which is known to release selectively only the G protein (Cartwright et al., 1970a, b) (Fig. 1 a) .
Apparently, the effect of detergent on adsorption of the virus proteins to PVC is primarily a reflection of an increase in the availability of these proteins as a result of disruption of the virus membrane and ribonucleoprotein core.
There was a linear correlation between the amount of virus proteins that adsorbed to the plates and their concentration in the tested sample (Fig. 1 b) . This binding formed the basis for a simple immunoassay for the virus protein which involved mixing the virus-containing sample with detergent solution, transfdrring a sample of the mixture to a PVC plate and then quantifying the virus protein which was bound to the PVC plates by sequential incubation with anti-VSV serum and ~25i.labelled Protein A (see Methods). The serum protein, present in rather high amounts in the cell growth medium, could not fully prevent binding of virus proteins to the PVC plates. The amount of virus protein formed within 2 h of infection was, in ceils of various human (Fig. 2) , monkey (Fig. 3) , bovine (Fig. 4) , and mouse cell lines (not shown), high enough to be quantified by this immunoassay. While initially this procedure was used for measuring the amount of virus protein in the growth medium of infected cells, we found it later convenient to add deoxycholate directly to the whole infected culture. The detergent lysed the cells and thus permitted measurement of the total amount of virus protein in the culture. The efficiency of binding virus protein to PVC in the presence of cell lysate appears to be lower than in its absence, probably due to competition of some cellular proteins with the virus proteins, for binding sites on the PVC (Fig. 1 b, medium plus cells). This competition, however, did not interfere with the assay since even in the presence of cell lysate the binding of virus proteins to PVC was linearly proportional to their concentration (Fig. 1 b) .
Application of the immunoassay for quantification of the antiviral effect of IFN
As seen in Fig. 2 , cells of various lines showed substantially reduced yields of virus protein after treatment with IFN. Comparison of the decrease in virus protein with the decrease in production of infectious virions, as measured by the plaque assay, showed that both responded similarly to IFN. The minimal IFN concentration at which the antiviral effect could be detected was about the same for the decrease of virus proteins and the decrease of infectious virions (Fig.  3) , Nevertheless, this comparison shows a clear advantage of the immunoassay over the plaque assay for measuring the antiviral effect at very low concentrations of IFN. The decrease of virus yield by a few percent at such IFN concentrations is much simpler to quantify accurately by the immunoassay than by the plaque assay. On the other hand, the immunoassay is clearly not applicable for measuring the antiviral effect of very high concentrations of IFN since it allows the quantification of viral proteins only at virus concentrations higher than about 106 p.f.u./ml (Fig. 3) .
On examining the morphology of the infected cells, we observed that protection from killing by the virus could only be detected with IFN concentrations higher than those causing a reduction in viral protein. To confirm this observation we have quantified the viral cytopathy by measuring the neutral red uptake capacity of the cells. Comparison of the yield of viral protein and the extent of viral cytopathy showed a more effective response of the former parameter to IFN (Fig. 4) . At a low concentration of IFN, effective reduction of viral protein with no increase of cell viability could be observed. Fig. 2 and 3 . A similar dissociation between the effect on viral cytopathy and on protein yield was observed with IFN-u (not shown).
DISCUSSION
The immunoassay described in this study for measuring the yield of virus protein provides a sensitive and quantitative tool for estimation of the antiviral effect of IFN. In several respects it is preferable to the 'cytopathic effect inhibition' assay which is now the method most widely applied for measuring the action of IFN; it gives a more direct quantification of the change induced by IFN and it is independent of the morphological response to the virus; in fact, it can even serve for estimating the effect of IFN on viruses which are not cytopathic at all, providing that antibodies against their proteins are available.
An interesting phenomenon revealed when comparing the sensitivity of the immunoassay and of the cytopathic effect assay is a difference in the IFN concentration dependence of the reduction in virus yield and in virus cytopathic effect. This difference is probably due to the existence of excess constituents of the virus in the infected cell, beyond the minimal amount necessary to cause destruction. Another factor which might have contributed to this phenomenon is the ability of IFN to induce increased sensitivity of the cells to virus cytopathy (Joklik & Merigan, 1966; Katz et al., 1974; Vethamany et al., 1977) . Practically, this difference in IFN concentration dependence implies that the immunoassay gives a more sensitive indication of the antiviral effect than that provided by the cytopathic effect inhibition assay.
We have tried to make the immunoassay as simple as possible so that it will be conveniently applicable for the many determinations involved in the assay of IFN. There are a number of different ways whereby solid-phase immunoassay can be performed. Steps can be taken to permit sensitive detection of very low quantities of antigen either by its enrichment, using plates which have been pre-coated with antibody ('sandwich' technique) or by using a highly labelled sample of antigen (competition radioimmunoassay). Yet the large amounts of VSV proteins found in infected cells, and their effective binding to PVC, allows their quantification by a very simple, direct immunoassay. A major attractive feature of this technique is that the amount of bound antigen is linearly proportional to its concentration in the culture, over a wide range of concentrations. It is, therefore, not necessary to dilute the samples before the test.
Although we are now aware of many different effects of IFN on cell functions, none is as ubiquitously observed and as specific to IFN as the antiviral effect. It is still the function by which we define IFN, and on which we usually base its bioassay. Techniques for accurate quantification of the antiviral effect of IFN, such as those presented in this study, might therefore contribute to further advance in this field.
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